Abstract

Background. Plasmid-mediated quinolone resistance (PMQR) has received considerable attention recently. Data analysis in Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER) revealed 75% of the Enterobacteriaceae isolates to be ciprofloxacin-resistant in 2012. Few reports regarding the prevalence of PMQR are available from India. Hence, the present study was carried out to ascertain the prevalence of PMQR genes among clinical isolates of ciprofloxacin-resistant Enterobacteriaceae in JIPMER.Methods. The study included 642 ciprofloxacin-resistant clinical Enterobacteriaceae isolates. JIPMER hospital’s annual consumption data for fluoroquinolones were retrieved from the Department of Pharmacy. The test isolates were screened for the presence of qnr A, B, D, S and aac(6′)-Ib-cr genes. PMQR-positive isolates alone were tested for the presence of class I (intI1) and class II (intI2) integrons. Randomly selected PCR amplicons were sequenced and analysed using MEGA software. A total of 30 PMQR strains chosen at random were assessed for the transferability of the PMQR genes.Results. A majority of the strains exhibited high MIC values with 106 strains exhibiting MIC values >256 µg/mL. The aac(6′)-Ib-cr gene had the highest prevalence at 64% (414) while, qnrB and qnrS genes were present in 15% (97) and 10% (64) of the isolates respectively. None of the strains were positive for qnrA and qnrD. All PMQR-positive isolates were screened for class I (intI1) and class II (intI2) integrons. Class I integron was found to be predominant among the test isolates with a few of them carrying both the classes of integrons. Transferability of PMQR genes to transconjugants was identified.Conclusion. The incidence of PMQR genes in the tertiary-care setup of the JIPMER hospital was found to be high which could be probably due to the increased prescription of fluoroquinolones. Thus, there is a need for rational usage of fluoroquinolones.

Highlights

  • Fluoroquinolone resistance among the Enterobacteriaceae is a serious public health problem as it is responsible for the rise in respiratory tract infections worldwide whereas, in Asia UTI and intra-abdominal infections are on the rise (Dalhoff, 2012)

  • We have reported the prevalence of Plasmid-mediated quinolone resistance (PMQR) determinants from a sample size of 642 ciprofloxacin-resistant Enterobacteriaceae clinical isolate, making our report the largest study of its kind so far in India

  • We have elucidated the prevalence of the plasmid-mediated quinolone resistance genes among clinical Enterobacteriaceae isolates recovered from a tertiary care hospital in Puducherry, India

Read more

Summary

Introduction

Fluoroquinolone resistance among the Enterobacteriaceae is a serious public health problem as it is responsible for the rise in respiratory tract infections worldwide whereas, in Asia UTI and intra-abdominal infections are on the rise (Dalhoff, 2012). Enterobacteriaceae isolates have exhibited a high level of fluoroquinolone resistance (Redgrave et al, 2014). Due to the increase in fluoroquinolone resistance, plasmid-mediated quinolone resistance (PMQR) has received considerable attention in recent years. The present study was carried out to ascertain the prevalence of PMQR genes among clinical isolates of ciprofloxacinresistant Enterobacteriaceae in JIPMER. The test isolates were screened for the presence of qnr A, B, D, S and aac(6 )-Ib-cr genes. PMQR-positive isolates alone were tested for the presence of class I (intI1) and class II (intI2) integrons. All PMQR-positive isolates were screened for class I (intI1) and class II (intI2) integrons. The incidence of PMQR genes in the tertiary-care setup of the JIPMER hospital was found to be high which could be probably due to the increased prescription of fluoroquinolones. There is a need for rational usage of fluoroquinolones

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call